N-acetylcysteine Protects Hepatocytes from Hypoxia-related Cell Injury

Overview

Journal Clin Exp Hepatol

Specialty Gastroenterology

Date 2019 Jan 4

PMID 30603674

Citations 5

Authors

Jan Heil

Daniel Schultze

Peter Schemmer

Helge Bruns

Affiliations

Soon will be listed here.

Abstract

Aim Of The Study: Hepatocyte transplantation has been discussed as an alternative to liver transplantation in selected cases of acute and chronic liver failure and metabolic diseases. Immediately after infusion of hepatocytes, hypoxia-related cell injury is inevitable. N-acetylcysteine (NAC) has been suggested to attenuate hypoxic damage. This study's objective was to evaluate NAC's protective effect in a model of hypoxia-related hepatocyte injury.

Material And Methods: HepG2 cells were used as a model for hepatocytes and were cultured under standardized hypoxia or normoxia for 24 hours with or without NAC. Growth kinetics were monitored using trypan blue staining. The activation of apoptotic pathways was measured using quantitative real-time PCR for Bcl-2/Bax and p53. The proportions of vital, apoptotic and necrotic cells were verified by fluorescence activated cell sorting using annexin V-labelling. The expression of hypoxia inducible factor 1 (HIF-1) was measured indirectly using its downstream target vascular endothelial growth factor A (VEGF-A).

Results: After NAC, cell proliferation increased under both hypoxia and normoxia by 528% and 320% ( < 0.05), while VEGF-A expression decreased under normoxia by 67% and 37% ( < 0.05). Compared to cells treated without NAC under hypoxia, the Bcl-2/Bax ratio increased significantly in cells treated with NAC. This finding was confirmed by an increased number of vital cells in FACS analysis.

Conclusions: NAC protects hepatocytes from hypoxic injury and ultimately activates anti-apoptotic pathways.

Citing Articles

Efect of N-acetylcysteine on HepG2 cells which were induced into fatty liver cells.

Gholamrezapour M, Taghizadeh Ghavamabadi R, Taghavi M, Dehghani Soltani S, Shabanizadeh A, Vazirinejad R J Mol Histol. 2024; 56(1):27.

PMID: 39630170 DOI: 10.1007/s10735-024-10313-2.

Chemical approaches targeting the hurdles of hepatocyte transplantation: mechanisms, applications, and advances.

Shi H, Ding Y, Sun P, Lv Z, Wang C, Ma H Front Cell Dev Biol. 2024; 12:1480226.

PMID: 39544361 PMC: 11560891. DOI: 10.3389/fcell.2024.1480226.

4-Methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene (MBP) exposure induces hepatotoxicity and nephrotoxicity - role of oxidative stress, mitochondrial dysfunction and pathways of cytotoxicity.

Maadurshni G, Nagarajan M, Mahalakshmi B, Sivasubramanian J, Hemamalini V, Manivannan J Toxicol Res (Camb). 2024; 13(5):tfae173.

PMID: 39417036 PMC: 11474237. DOI: 10.1093/toxres/tfae173.

Establishment of a hypobaric hypoxia-induced cell injury model in PC12 cells.

Zhang D, Cao Q, Jing L, Zhao X, Ma H Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022; 50(5):614-620.

PMID: 34986528 PMC: 8732250. DOI: 10.3724/zdxbyxb-2021-0343.

N-acetylcysteine maintains penile length and erectile function in bilateral cavernous nerve crush rat model by reducing penile fibrosis.

Ma M, Wu C, Zhang P, Li T, Wei S, Yu B Asian J Androl. 2020; 23(2):215-221.

PMID: 32394901 PMC: 7991820. DOI: 10.4103/aja.aja_17_20.

References

Gupta S, Bhargava K, Novikoff P . Mechanisms of cell engraftment during liver repopulation with hepatocyte transplantation. Semin Liver Dis. 1999; 19(1):15-26. DOI: 10.1055/s-2007-1007094. View

Zafarullah M, Li W, Sylvester J, Ahmad M . Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci. 2003; 60(1):6-20. PMC: 11138873. DOI: 10.1007/s000180300001. View

Mitry R, Hughes R, Aw M, Terry C, Mieli-Vergani G, Girlanda R . Human hepatocyte isolation and relationship of cell viability to early graft function. Cell Transplant. 2003; 12(1):69-74. DOI: 10.3727/000000003783985197. View

Gupta S, Wilson J, Chowdhury J . Hepatocyte transplantation: development of new systems for liver repopulation and gene therapy. Semin Liver Dis. 1992; 12(3):321-31. DOI: 10.1055/s-2008-1040401. View

Smith M, Peters M, Richardson T, Garbern J, Mooney D . Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng. 2004; 10(1-2):63-71. DOI: 10.1089/107632704322791709. View

Lange C, Schroeder J, Stute N, Lioznov M, Zander A . High-potential human mesenchymal stem cells. Stem Cells Dev. 2005; 14(1):70-80. DOI: 10.1089/scd.2005.14.70. View

Lange C, Bassler P, Lioznov M, Bruns H, Kluth D, Zander A . Hepatocytic gene expression in cultured rat mesenchymal stem cells. Transplant Proc. 2005; 37(1):276-9. DOI: 10.1016/j.transproceed.2004.11.087. View

Polson J, Lee W . AASLD position paper: the management of acute liver failure. Hepatology. 2005; 41(5):1179-97. DOI: 10.1002/hep.20703. View

Lange C, Bassler P, Lioznov M, Bruns H, Kluth D, Zander A . Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol. 2005; 11(29):4497-504. PMC: 4398698. DOI: 10.3748/wjg.v11.i29.4497. View

10.

Oh S, Lim S . A rapid and transient ROS generation by cadmium triggers apoptosis via caspase-dependent pathway in HepG2 cells and this is inhibited through N-acetylcysteine-mediated catalase upregulation. Toxicol Appl Pharmacol. 2005; 212(3):212-23. DOI: 10.1016/j.taap.2005.07.018. View

11.

Zwingmann C, Bilodeau M . Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology. 2006; 43(3):454-63. DOI: 10.1002/hep.21075. View

12.

Fiegel H, Bruns H, Hoper C, Lioznov M, Kluth D . Cell growth and differentiation of different hepatic cells isolated from fetal rat liver in vitro. Tissue Eng. 2006; 12(1):123-30. DOI: 10.1089/ten.2006.12.123. View

13.

Roy H, Bhardwaj S, Yla-Herttuala S . Biology of vascular endothelial growth factors. FEBS Lett. 2006; 580(12):2879-87. DOI: 10.1016/j.febslet.2006.03.087. View

14.

Fisher R, Strom S . Human hepatocyte transplantation: worldwide results. Transplantation. 2006; 82(4):441-9. DOI: 10.1097/01.tp.0000231689.44266.ac. View

15.

Harrison P, Wendon J, Gimson A, Alexander G, Williams R . Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med. 1991; 324(26):1852-7. DOI: 10.1056/NEJM199106273242604. View

16.

Hogquist K, Nett M, UNANUE E, Chaplin D . Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci U S A. 1991; 88(19):8485-9. PMC: 52533. DOI: 10.1073/pnas.88.19.8485. View

17.

Lee W, Hynan L, Rossaro L, Fontana R, Stravitz R, Larson A . Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009; 137(3):856-64, 864.e1. PMC: 3189485. DOI: 10.1053/j.gastro.2009.06.006. View

18.

Saito C, Zwingmann C, Jaeschke H . Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology. 2009; 51(1):246-54. PMC: 2977522. DOI: 10.1002/hep.23267. View

19.

Koch A, Trautwein C . N-acetylcysteine on its way to a broader application in patients with acute liver failure. Hepatology. 2009; 51(1):338-40. DOI: 10.1002/hep.23484. View

20.

Stephenne X, Najimi M, Sokal E . Hepatocyte cryopreservation: is it time to change the strategy?. World J Gastroenterol. 2009; 16(1):1-14. PMC: 2799904. DOI: 10.3748/wjg.v16.i1.1. View